,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast', 'bcsm', 'destiny-breast04']
breaking #asco22 news: novel anti-body drug conjugate doubles progression-free survival in her2-low metastatic breast cancer. dr. modi breaks down some of the findings in the destiny-breast04 trial. #bcsm 
True Marketeer, works at Parexel, one who literally lives to eat(ing) and read(ing) in that order &..& (Self-proclaimed) arbiter of taste. guess